Nora Sullivan Net Worth

The estimated Net Worth of Nora B Sullivan is at least $414 Thousand dollars as of 16 May 2022. Ms. Sullivan owns over 100,000 units of 22nd Century Inc stock worth over $212,633 and over the last 11 years she sold XXII stock worth over $0. In addition, she makes $201,220 as Chairman of the Board at 22nd Century Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Sullivan XXII stock SEC Form 4 insiders trading

Nora has made over 6 trades of the 22nd Century Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently she exercised 100,000 units of XXII stock worth $139,000 on 16 May 2022.

The largest trade she's ever made was exercising 138,376 units of 22nd Century Inc stock on 24 February 2021 worth over $131,457. On average, Nora trades about 12,932 units every 110 days since 2013. As of 16 May 2022 she still owns at least 748,707 units of 22nd Century Inc stock.

You can see the complete history of Ms. Sullivan stock trades at the bottom of the page.

Nora Sullivan biography

Nora B. Sullivan J.D. serves as Chairman of the Board of the Company. Ms. Sullivan is also currently President of Sullivan Capital Partners, LLC, a financial services company providing investment banking and consulting services to businesses seeking growth through acquisitions, strategic partnerships and joint venture relationships. Her experience includes the development and advancement of strategic initiatives and the implementation of best practice governance policies. Prior to founding Sullivan Capital Partners in 2004, Ms. Sullivan worked for Citigroup Private Bank from 2000 to 2004, providing capital markets and wealth management services to high net worth individuals and institutional clients. From 1995 to 1999, Ms. Sullivan was Executive Vice President of Rand Capital Corporation (NASDAQ: RAND), a publicly traded closed-end investment management company providing capital and managerial expertise to small and mid-size businesses. Ms. Sullivan is also a member of the Boards of Directors of Evans Bancorp, Inc. (NYSE American: EVBN), Robinson Home Products, and Rosina Food Products. She is also a member of the Investment Committee of the Patrick P Lee Foundation, Chairman of the Technology Transfer Committee of the Roswell Park Comprehensive Cancer Center, and a member of the Board of Directors of the Cortland College Foundation. Ms. Sullivan holds an M.B.A. Degree in Finance and International Business from Columbia University Graduate School of Business and a Juris Doctor degree from the University of Buffalo School of Law. Ms. Sullivan’s experience in governance matters and with mergers and acquisitions led to our conclusion that she should serve as a director.

What is the salary of Nora Sullivan?

As the Chairman of the Board of 22nd Century Inc, the total compensation of Nora Sullivan at 22nd Century Inc is $201,220. There are 4 executives at 22nd Century Inc getting paid more, with James A. Mish having the highest compensation of $1,140,872.

How old is Nora Sullivan?

Nora Sullivan is 62, she's been the Chairman of the Board of 22nd Century Inc since 2020. There are 5 older and 7 younger executives at 22nd Century Inc. The oldest executive at 22nd Century Group Inc is Roger O'Brien, 71, who is the Independent Director.

What's Nora Sullivan's mailing address?

Nora's mailing address filed with the SEC is 6460 MAIN STREET, , WILLIAMSVILLE, NY, 14221.

Insiders trading at 22nd Century Inc

Over the last 11 years, insiders at 22nd Century Inc have traded over $3,035,006 worth of 22nd Century Inc stock and bought 652,225 units worth $737,196 . The most active insiders traders include Andrew Arno, Joseph Pandolfino, and Michael Zercher. On average, 22nd Century Inc executives and independent directors trade stock every 80 days with the average trade being worth of $16,372. The most recent stock trade was executed by Lawrence Firestone on 30 May 2024, trading 9,000 units of XXII stock currently worth $9,810.

What does 22nd Century Inc do?

with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.

Complete history of Ms. Sullivan stock trades at 22nd Century Inc and Evans Bancorp Inc

22nd Century Inc executives and stock owners

22nd Century Inc executives and other stock owners filed with the SEC include:

• James A. Mish,
  Chief Exec. Officer
• Michael J. Zercher,
  Pres & COO
• John Brodfuehrer,
  Vice President - Strategy
• John E. Franzino,
  Chief Admin. Officer
• Nora Sullivan,
  Chairman of the Board
• Michael Koganov,
  Independent Director
• James Mish,
  Chief Executive Officer
• John Franzino,
  Chief Financial Officer
• Mei Kuo,
  Director of Communications and Investor Relations
• Lisa Parks,
  Vice President - Acquisitions
• Roger O'Brien,
  Independent Director
• Richard Sanders,
  Independent Director
• Juan Tamburrino,
  Vice President - Research & Development
• Michael Zercher,
  President, Chief Operating Officer
• Dr. Calvin Treat,
  Chief Scientific Officer
• R. Hugh Kinsman,
  Chief Financial Officer
• James C. Morrison,
  Technical Advisor & Regulatory Affairs Consultant
• Henry Sicignano III, M.B.A., MBA,
  Consultant
• Steven Przybyla,
  VP, Gen. Counsel & Corp. Sec.
• Richard F. Fitzgerald CPA, CPA,
  Chief Financial Officer
• Lucille S Salhany,
  Director
• Andrew Arno,
  Director
• Joseph A Dunn,
  Director
• Paul Rushton,
  VP of Plant Biotechnology
• James E. Swauger,
  Senior VP-Science & Regulatory
• Thomas L. James,
  VP, General Counsel & Sec'y.
• Henry Iii Sicignano,
  President and Secretary
• Michael Robert Moynihan,
  Vice President of R&D
• James W Cornell,
  Director
• Joseph Pandolfino,
  Chief Executive Officer
• Partners, Llc Clearwater,
  10% owner
• Richard G Saffire,
  10% owner
• Clifford B Fleet,
  Director
• Andrea S Jentsch,
  Chief Financial Officer
• Richard F Fitzgerald,
  Chief Financial Officer
• Anthony L. Johnson,
  Director
• Peter Ferola,
  Chief Legal Officer & Secy.
• John J Miller,
  President, Tobacco
• Robert Hugh Kinsman,
  Chief Financial Officer
• Lawrence Firestone,
  Chief Executive Officer